Corcept Therapeutics Incorporated.
(NASDAQ : CORT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
1.58%34.6821.1%$126.04m
PRGOPerrigo Co. Plc
3.64%72.966.7%$115.08m
SHPGShire PLC Sponsored ADR
-0.63%170.420.4%$114.29m
ENDPEndo International Plc
-1.94%15.648.9%$89.03m
JAZZJazz Pharmaceuticals Plc
0.40%173.812.2%$72.23m
ICPTIntercept Pharmaceuticals, Inc.
0.20%103.4218.7%$68.63m
SAGESAGE Therapeutics, Inc.
2.03%152.089.6%$57.16m
UTHRUnited Therapeutics Corporation
-2.97%125.6114.4%$50.56m
CTLTCatalent Inc
0.39%40.942.6%$47.83m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.59%136.066.8%$43.22m
PTLAPortola Pharmaceuticals, Inc.
0.04%25.597.7%$40.54m
SUPNSupernus Pharmaceuticals, Inc.
2.99%44.806.2%$40.22m
ICLRICON Plc
0.23%143.684.2%$39.99m
ZGNXZogenix, Inc.
1.15%48.6011.9%$37.44m
HZNPHorizon Pharma plc
-0.15%20.577.5%$32.74m

Company Profile

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.